Skandinaviska Enskilda Banken (SEB)
VERA icon

Skandinaviska Enskilda Banken (SEB)’s Vera Therapeutics VERA Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-22,290
Closed -$525K – 889
2025
Q2 		$525K Hold
22,290
– – ﹤0.01% 698
2025
Q1 		$535K Hold
22,290
– – ﹤0.01% 682
2024
Q4 		$938K Buy
22,290
+5,189
+30% +$230K ﹤0.01% 661
2024
Q3 		$756K Buy
+17,101
New +$649K ﹤0.01% 692

Other funds holding VERA

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s VERA Position: Q3 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Vera Therapeutics (VERA) in Q3 2025, closing a stake of 22,290 shares — an estimated $525K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in VERA in Q3 2024 and held it in 4 quarters. The position peaked at $938K in Q4 2024. 175 funds tracked by Wall St. Rank hold VERA as of Q3 2025.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Vera Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 22,290 Vera Therapeutics shares in Q3 2025, an estimated $525K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Vera Therapeutics in Q3 2024 and held it in 4 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Vera Therapeutics position peaked at $938K in Q4 2024.
  • 175 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2025, filed 7 Nov 2025.